LOC93429: A Potential Drug Target Or Biomarker for Cancer and Inflammation

Target Name: LOC93429

NCBI ID: G93429

LOC93429

Other Name(s): Uncharacterized LOC93429 | uncharacterized LOC93429

LOC93429: A Potential Drug Target Or Biomarker for Cancer and Inflammation

LOC93429 is a protein that is expressed in various tissues throughout the body. It is a member of the LOC93 family of proteins, which are known for their role in intracellular signaling. LOC93429 is primarily expressed in the liver, and it has been shown to play a role in the regulation of a variety of cellular processes, including cell growth, apoptosis, and inflammation.

Recent studies have suggested that LOC93429 may be a drug target or biomarker for a variety of diseases. For example, LOC93429 has been shown to be involved in the development and progression of liver cancer, and it has been shown to be expressed in the liver cancer cells. Additionally, LOC93429 has been shown to be involved in the regulation of cellular apoptosis, and it has been shown to play a role in the execution of cell death in the body.

These studies have led some researchers to speculate that LOC93429 may be a potential drug target or biomarker for liver cancer and other diseases. Further research is needed to confirm these predictions and to fully understand the role of LOC93429 in these processes.

Protein Name: Uncharacterized LOC93429

The "LOC93429 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC93429 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets